Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (31-40 of 1,153) with videos related to

Pageof 116
Sort By:
Postgraduate Medicine|August 12, 2009
New treatment strategies for high-risk dyslipidemic patients. IntroductionChristie M Ballantyne
Transactions of the American Clinical and Climatological Association|July 18, 2020
PRECISION MEDICINE FOR CARDIOVASCULAR DISEASE PREVENTION: WHERE DO WE STAND IN 2019 WITH A FOCUS ON INFLAMMATION AND LIPIDS?Christie M Ballantyne
Journal of the American College of Cardiology|June 25, 2021
Statins and Your Memory: "Forget" About It?Christie M Ballantyne, Vijay Nambi
Atherosclerosis. Supplements|April 13, 2005
Markers of inflammation and their clinical significanceChristie M Ballantyne, Vijay Nambi
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 1, 1997
Does the method of payment affect anaesthetic practice? An evaluation of an alternate payment planP G Duncan, M Ballantyne
Current Cardiology Reports|September 12, 2000
Inflammation and lipid-lowering treatmentC M Ballantyne, Y Abe
Current Atherosclerosis Reports|September 25, 2016
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate LyaseOzlem Bilen, Christie M Ballantyne
Applied Optics|March 10, 2010
Random fluctuations in first-order waveguide grating filtersA Basu, J M Ballantyne
Nature Reviews. Cardiology|May 12, 2017
Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemiaHuaizhu Wu, Christie M Ballantyne
Circulation|January 28, 2009
"Risky business": ten years is not a lifetimeVijay Nambi, Christie M Ballantyne
Pageof 116

Showing results (31-40 of 1,153) with videos related to

Sort By:
Pageof 116
Postgraduate Medicine|August 12, 2009
New treatment strategies for high-risk dyslipidemic patients. IntroductionChristie M Ballantyne
Transactions of the American Clinical and Climatological Association|July 18, 2020
PRECISION MEDICINE FOR CARDIOVASCULAR DISEASE PREVENTION: WHERE DO WE STAND IN 2019 WITH A FOCUS ON INFLAMMATION AND LIPIDS?Christie M Ballantyne
Journal of the American College of Cardiology|June 25, 2021
Statins and Your Memory: "Forget" About It?Christie M Ballantyne, Vijay Nambi
Atherosclerosis. Supplements|April 13, 2005
Markers of inflammation and their clinical significanceChristie M Ballantyne, Vijay Nambi
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 1, 1997
Does the method of payment affect anaesthetic practice? An evaluation of an alternate payment planP G Duncan, M Ballantyne
Current Cardiology Reports|September 12, 2000
Inflammation and lipid-lowering treatmentC M Ballantyne, Y Abe
Current Atherosclerosis Reports|September 25, 2016
Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate LyaseOzlem Bilen, Christie M Ballantyne
Applied Optics|March 10, 2010
Random fluctuations in first-order waveguide grating filtersA Basu, J M Ballantyne
Nature Reviews. Cardiology|May 12, 2017
Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemiaHuaizhu Wu, Christie M Ballantyne
Circulation|January 28, 2009
"Risky business": ten years is not a lifetimeVijay Nambi, Christie M Ballantyne
Pageof 116